{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:06:15Z","timestamp":1792087575050,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>We sought to characterize the incidence of chronic opioid dependence among head and neck cancer survivors treated by radiation, as well as to identify patient and treatment factors associated with persistent use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>The medical records of patients with head and neck cancer who received radiation therapy from January 2012 to July 2016 were reviewed. All patients received 60 to 70\u2009Gy with curative intent. Patients who progressed or died within 1 year were intentionally excluded. Opioid doses were calculated in morphine equivalent daily doses in milligrams (mg). Univariate and multivariate regression models were used to identify associations between demographic, medical, disease, and persistent opioid use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Two hundred and sixty-one patients were included. The median follow-up was 39 months (range: 12 to 83\u2009mo). Two hundred and eleven patients (80%) received opioids for pain control during radiation. The median morphine equivalent daily dose during treatment was 73.8\u2009mg (range: 5 to 561\u2009mg). Rates of persistent opioid use at 6 months, 1 year, and 2 years from completion of radiation were 41.8%, 30.1%, and 26.0%, respectively. On multivariate analysis, only preradiation opioid use correlated with persistent opioid use at all 3 time points (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). Smoking history and a Charlson comorbidity index \u22652 predicted for persistent opioid use at some time points, but not all.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>High rates of persistent opioid use exist in patients with head and neck cancer after radiation therapy. Early interventions to appropriately wean patients should be further investigated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000896","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T08:00:28Z","timestamp":1644307228000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and Predictors of Persistent Opioid Use in Survivors of Head and Neck Cancer Treated With Curative Radiation"],"prefix":"10.1097","volume":"45","author":[{"given":"Rohit","family":"Ganju","sequence":"first","affiliation":[{"name":"University of Kansas School of Medicine, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Neeranjun","sequence":"additional","affiliation":[{"name":"University of Kansas School of Medicine, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Morse","sequence":"additional","affiliation":[{"name":"University of Kansas School of Medicine, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lominska","sequence":"additional","affiliation":[{"name":"University of Kansas School of Medicine, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindi","family":"TenNapel","sequence":"additional","affiliation":[{"name":"University of Kansas School of Medicine, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen M.","family":"Chen","sequence":"additional","affiliation":[{"name":"Irvine Chao Family Comprehensive Cancer Center, University of California, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.semradonc.2017.04.008","article-title":"Management of radiation toxicity in head and neck cancers","volume":"27","author":"Siddiqui","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ijrobp.2016.08.046","article-title":"The impact of radiation treatment time on survival in patients with head and neck cancer","volume":"96","author":"Shaikh","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1758-3284-1-26","article-title":"Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy","volume":"1","author":"Epstein","year":"2009","journal-title":"Head Neck Oncol"},{"key":"R4-20250527","first-page":"Cd012592","article-title":"Opioids for cancer pain\u2014an overview of Cochrane reviews","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMp1714529","article-title":"The Public and the Opioid-Abuse Epidemic","volume":"378","author":"Blendon","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"key":"R8-20250527","first-page":"569","article-title":"US and states ramp up response to opioid crisis: regulatory, legislative, and legal tools brought to bear","volume":"42","author":"Barlas","year":"2017","journal-title":"P T"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11920-017-0811-9","article-title":"Psychosocial issues in patients with head and neck cancer: an updated review with a focus on clinical interventions","volume":"19","author":"Smith","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"R10-20250527","first-page":"1","article-title":"2013 NCHS Urban-Rural Classification Scheme for Counties","volume":"2","author":"Ingram","year":"2014","journal-title":"Vital Health Stat"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","article-title":"Quantifying the epidemic of prescription opioid overdose deaths","volume":"108","author":"Seth","year":"2018","journal-title":"Am J Public Health"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/joms.2002.31224","article-title":"Follow-up in patients with oral cancer","volume":"60","author":"Gellrich","year":"2002","journal-title":"J Oral Maxillofac Surg"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1634\/theoncologist.2013-0001","article-title":"Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer","volume":"18","author":"Kwon","year":"2013","journal-title":"Oncologist"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2019.03.007","article-title":"Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies","volume":"92","author":"Smith","year":"2019","journal-title":"Oral Oncol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0194599818808513","article-title":"Short- and long-term opioid use in patients with oral and oropharynx cancer","volume":"160","author":"McDermott","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0194599820960137","article-title":"Implications of treatment modality on chronic opioid use following treatment for head and neck cancer","volume":"164","author":"Bollig","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hed.25482","article-title":"Effect of treatment modality on chronic opioid use in patients with T1\/T2 oropharyngeal cancer","volume":"41","author":"Bollig","year":"2019","journal-title":"Head Neck"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/lary.27791","article-title":"Chronic opioid use in patients undergoing treatment for oropharyngeal cancer","volume":"129","author":"Silver","year":"2019","journal-title":"Laryngoscope"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/hed.26034","article-title":"Long-term opioid use in curative-intent radiotherapy: one-year outcomes in head\/neck cancer patients","volume":"42","author":"Schumacher","year":"2020","journal-title":"Head Neck"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40463-021-00508-y","article-title":"Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction","volume":"50","author":"Hinther","year":"2021","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.18.00938","article-title":"Trends in opioid use among older survivors of colorectal, lung, and breast cancers","volume":"37","author":"Salz","year":"2019","journal-title":"J Clin Oncol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2012.01.002","article-title":"Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer","volume":"103","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1055-9965.EPI-16-1023","article-title":"Trends in radiation therapy among cancer survivors in the United States, 2000-2030","volume":"26","author":"Bryant","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"Jama"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","article-title":"US National trends in opioid-related hospitalizations among patients with cancer","volume":"5","author":"Chua","year":"2019","journal-title":"JAMA Oncol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00520-008-0497-y","article-title":"The cognitive effects of opioids in cancer: a systematic review","volume":"17","author":"Kurita","year":"2009","journal-title":"Support Care Cancer"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejcsup.2013.07.008","article-title":"Drug-associated delirium in cancer patients","volume":"11","author":"Caraceni","year":"2013","journal-title":"EJC Suppl"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/pme.12777","article-title":"Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in veterans\u2019 health administration patients","volume":"16","author":"Zedler","year":"2015","journal-title":"Pain Med"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pain.2009.05.006","article-title":"Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders","volume":"145","author":"Weisner","year":"2009","journal-title":"Pain"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMsa1610524","article-title":"Opioid prescribing by emergency physicians and risk of long-term use","volume":"376","author":"Barnett","year":"2017","journal-title":"N Engl J Med"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.2017-0248","article-title":"Outcomes of a specialized interdisciplinary approach for patients with cancer with aberrant opioid-related behavior","volume":"23","author":"Arthur","year":"2018","journal-title":"Oncologist"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa011871","article-title":"The effect of group psychosocial support on survival in metastatic breast cancer","volume":"345","author":"Goodwin","year":"2001","journal-title":"N Engl J Med"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.1833","article-title":"Trends in long-term opioid therapy for chronic non-cancer pain","volume":"18","author":"Boudreau","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:07:07Z","timestamp":1748365627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000896","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}